Target intelligence / Profile preview

Natural killer group 2 member D ligand family (NKG2DL)

Target
NKG2DL
Molecular classification
Receptor ligand, Stress-inducible cell surface protein
01

Overview

The Natural killer group 2 member D ligand family comprises a set of stress-inducible cell surface proteins that serve as key recognition molecules for innate immunity. In humans, this family includes two major groups: MHC class I polypeptide-related sequence A/B (MICA/MICB) proteins and UL16-binding proteins (ULBP1–6), also known as retinoic acid early transcript 1 (RAET1) proteins. These ligands are normally expressed at low levels but are upregulated during cellular stress—such as infection by viruses/bacteria or malignant transformation—and act as "danger signals" that alert cytotoxic lymphocytes expressing the activating receptor NKG2D. Upon binding these ligands on stressed cells—including infected cells and many types of tumors—the NKG2D receptor triggers activation signals in natural killer cells and certain T-cell subsets such as CD8+ αβ T cells and γδ T cells. This leads to targeted killing through release of cytotoxic granules containing perforin/granzymes along with cytokine secretion amplifying overall immunity. Polymorphisms within MICA/MICB genes affect their affinity for binding receptors like NKG2D which has implications not only in cancer immunosurveillance but also organ transplantation compatibility where mismatches may increase rejection risks. Soluble forms shed from tumor surfaces can suppress anti-tumor immunity by downregulating surface expression while circulating forms may serve diagnostic/prognostic markers reflecting disease status especially cancers like colon adenocarcinoma where differential gene expressions correlate with clinical outcomes.[3][5][7]

Other names
NKG2D ligandsMHC class I polypeptide-related sequence A/B (MICA/B)UL16-binding protein (ULBP) familyretinoic acid early transcript 1 (RAET1) family
02

Biological functions

Immune responseSignal transductionCell stress recognitionTumor immunosurveillanceAntiviral immunity
03

Disease associations

Cancer (tumor immune surveillance and escape)Infection (viral and bacterial)Autoimmune disease risk factor due to polymorphism effects on immune activation
04

Safety considerations

Potential risk of autoimmunity due to aberrant expression or shedding of NKG2DLtumor immune escape via downregulation or shedding of ligands from tumor cell surfacespossible adverse effects if therapeutic strategies inadvertently suppress beneficial immune responses
05

Biomarkers

MICA/B polymorphisms as biomarkers in organ transplantation outcomes and cancer prognosissoluble MICA/B levels as potential biomarkers for tumor progression or immune evasion

Beyond the preview

Go deeper on Natural killer group 2 member D ligand family (NKG2DL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natural killer group 2 member D ligand family (NKG2DL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call